Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

Name: Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
License: Public Domain

Northwestern University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent b-cell non-hodgkin lymphoma, recurrent polymorphic post-transplant lymphoproliferative disorder, refractory b-cell non-hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 201785
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.